Lakewood-Amedex Biotherapeutics Inc. (LABT) Stock

NASDAQ: LABTHealthcare company in the biotechnology industry, based in University Park, FL.

Lakewood-Amedex Biotherapeutics stock price chart

LABT interactive chart →

LABT stock quote & key statistics

Lakewood-Amedex Biotherapeutics earnings per share

Income →
Earnings per share

Lakewood-Amedex Biotherapeutics revenue & net income

Income →
RevenueNet income

Lakewood-Amedex Biotherapeutics annual financials

Income statement →
Fiscal yearRevenueNet incomeEPS
FY2025$0-$3.8M—
FY2024$0-$4.9M—
FY2023$0-$8.3M—

Fiscal year ending December 31. Source: company filings via EODHD.

About Lakewood-Amedex Biotherapeutics Inc.

Lakewood-Amedex Biotherapeutics, Inc. operates as a clinical-stage biotechnology company that develops antimicrobial products in the United States. The company offers products from its Bisphosphocin class, a novel class of antimicrobial agents a broad range of infections, including those affecting the skin, bladder, and lungs. It also develops Nu-3, a topical antimicrobial for infected diabetic foot ulcers, which is in Phase 2b clinical trial.

The company was formerly known as Lakewood-Amedex Inc. and changed its name to Lakewood-Amedex Biotherapeutics, Inc. in June 2025. Lakewood-Amedex Biotherapeutics, Inc. was incorporated in 2006 and is headquartered in University Park, Florida.

Lakewood-Amedex Biotherapeutics stock FAQ

What is the Lakewood-Amedex Biotherapeutics stock ticker symbol?

Lakewood-Amedex Biotherapeutics Inc. trades on the NASDAQ under the ticker symbol LABT.

What sector and industry is Lakewood-Amedex Biotherapeutics in?

Lakewood-Amedex Biotherapeutics Inc. is classified in the Healthcare sector, Biotechnology industry.

How many employees does Lakewood-Amedex Biotherapeutics have?

Lakewood-Amedex Biotherapeutics Inc. has about 5 full-time employees.

What were Lakewood-Amedex Biotherapeutics's revenue and earnings last fiscal year?

Lakewood-Amedex Biotherapeutics reported revenue of $0 and net income of -$3.8M in fiscal 2025.

When did Lakewood-Amedex Biotherapeutics go public?

Lakewood-Amedex Biotherapeutics stock began trading on April 23, 2026.

Biotechnology stocks

All Healthcare stocks →